← FDA DRUG APPROVALS

FDA ANDA · ANDA076616

OFLOXACIN

Sponsor: HIKMA

APPLICATION
ANDA076616
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-17
LATEST ACTION
2013-08-13
ROUTE
OTIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

OFLOXACINDiscontinued
OFLOXACIN 0.3% · SOLUTION/DROPS · OTIC

Approval history

2013-08-13Labeling · Supplement 3 · standardAP
2010-05-10Labeling · Supplement 1AP
2008-03-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →